Experiments demonstrate DDA1 phosphorylation promotes DNA repair in glioblastoma, suggesting mTORC1 plays a vital role.
Abstract The protein DDA1 is involved in protein degradation, cell cycle regulation, and DNA damage repair. Recent studies have revealed its differential expression across various tumor types. However, the manner in which how DDA1 functions as a tumorigenic factor remains to be elucidated. Through experiments in multiple glioblastoma cell models, we identified a physical association between cytoplasmic DDA1 and Raptor, a key component of lysosome-associated mTORC1. Amino acid stimulation triggers phosphorylation of DDA1 at serine 33, promoting its nuclear translocation and involvement in DNA damage repair. Integrated genomic and transcriptomic analysis revealed that the amino-acid-mTORC1-DDA1S33-DNA repair axis regulates the expression of a subset of metabolic genes, including ENO2, a glycolytic enzyme; CA12, which contributes to intracellular and extracellular pH homeostasis; and NMRK1, a key enzyme in nicotinamide riboside metabolism. Notably, DDA1 deficiency markedly impaired glioblastoma growth and triggered a compensatory upregulation of metabolic activity to sustain tumor cell survival. These metabolic genes supply essential nutrients required for effective DNA repair. Our findings establish DDA1 as a previously unrecognized phosphorylation target downstream of amino-acid-mTORC1, serving as both a critical mediator of mTORC1-driven DNA damage response and a key regulator of glioblastoma progression, thereby expanding our understanding of gliomagenesis.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: